Product

Sodium-glucose cotransporter-2 inhibitors

Aliases

Sodium-glucose cotransporter-2 inhibitors (SGLT2i)

1 clinical trial

2 indications

Indication

chronic kidney disease

Indication

Type 2 Diabetes

Clinical trial

Finerenone on Top of SGLT2is: A coMparatIve Hybrid Study Based oN RCT/RWE Data Of Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

Status: Completed, Estimated PCD: 2023-12-20